Advertisement
Canada markets open in 9 hours 30 minutes
  • S&P/TSX

    21,656.05
    +13.18 (+0.06%)
     
  • S&P 500

    5,022.21
    -29.20 (-0.58%)
     
  • DOW

    37,753.31
    -45.66 (-0.12%)
     
  • CAD/USD

    0.7272
    +0.0008 (+0.12%)
     
  • CRUDE OIL

    82.91
    +0.22 (+0.27%)
     
  • Bitcoin CAD

    85,233.36
    -2,576.88 (-2.93%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • GOLD FUTURES

    2,389.20
    +0.80 (+0.03%)
     
  • RUSSELL 2000

    1,947.95
    -19.53 (-0.99%)
     
  • 10-Yr Bond

    4.5850
    -0.0740 (-1.59%)
     
  • NASDAQ futures

    17,726.00
    +67.50 (+0.38%)
     
  • VOLATILITY

    18.21
    -0.19 (-1.03%)
     
  • FTSE

    7,847.99
    +27.63 (+0.35%)
     
  • NIKKEI 225

    38,110.65
    +148.85 (+0.39%)
     
  • CAD/EUR

    0.6807
    +0.0005 (+0.07%)
     

Chipotle free drink promotion; T-Mobile upgrade; Credit Suisse bullish on Lululemon

Yahoo Finance is tracking the stocks you’re following, based on your Yahoo Finance ticker searches.

Chipotle (CMG) — The company announced that it will give a free soda drink or iced tea to all high school and college students with the purchase of an entrée during the month of September.

T-Mobile (TMUS) — Wells Fargo upgraded the wireless carrier to outperform from market perform as it expected free cash flow to “significantly ramp up” next year.

Lululemon Athletics (LULU) — Credit Suisse (CS) maintains its bullish view on the retailer. The investment firm backed its outperform rating on the stock with a $76 price target on expectation of strong pricing and normalized inventory.

ADVERTISEMENT

FitBit (FIT) — The company has released sequels to its Charge and Flex. The two devices, the Charge 2 and Flex 2, will sell for $149.95 and $99.95 respectively.

Southwest (LUV) — The airline has called the mid-air blow up of an engine an isolated incident. A flight had to execute an emergency landing after some cabin pressure was lost.

Mylan (MYL) — The company has announced that it will launch its first generic EpiPen at a discount of more than 50% from the list price of its branded products. The announcement comes just days after Mylan came under fire for hiking the price of its branded drug by more than 500% in eight years.